Qhov txawv ntawm Liraglutide thiab Semaglutide yog dab tsi?

Taw qhia

Liraglutidethiab Semaglutide muaj qhov chaw nrog chav kawm ntawm cov tshuaj hu ua glucagon-zoo li peptide-1 (GLP-1) receptor agonists. Cov tshuaj no yog siv los kho mob ntshav qab zib hom 2 thiab pab tib neeg kom nyias nyias. Cov tshuaj no muab cov cuab yeej sib piv ntawm kev ua ub no, txawm li cas los xij lawv txawv qhov tseem ceeb. Hauv qhov kev nkag blog no, peb yuav tham txog qhov sib txawv ntawm Liraglutide thiab Semaglutide, nrog rau liraglutide pab tib neeg kom nyias nyias, nws tuaj yeem ua rau muaj txiaj ntsig zoo li cas, thiab nws pab kho li cas nrog 2 ntshav qab zib.

Liraglutide ua haujlwm li cas rau kev poob phaus?

Liraglutide, txhawb nqa raws li lub npe lag luam Saxenda rau kev txo qhov hnyav, yog GLP-1 receptor agonist uas ua raws li cov kev cuam tshuam ntawm cov tshuaj nquag tshwm sim GLP-1. Thaum tswj hwm, Liraglutide txuas rau thiab ua rau GLP -1 receptors hauv lub cev, ua rau qee qhov kev poob phaus ua ntej cuam tshuam.

Ib txoj hauv kev tseem ceeb ntawm Liraglutide txhawb kev poob phaus yog los ntawm kev ua kom muaj kev xav ntawm satiety thiab txo qis qab los noj mov. Los ntawm kev ua ntawm GLP-1 receptors nyob rau hauv lub hlwb, tshwj xeeb tshaj yog nyob rau hauv lub hypothalamus, Liraglutide pab tswj kev tshaib kev nqhis thiab tag nrho cov cim. Qhov no ua rau txo qis hauv calories kom tsawg, raws li cov tib neeg xav tias txaus siab rau qhov me me thiab muaj kev xav tau tsawg dua.

Txawm hais tias nws qhov tshwm sim rau kev ntshaw,LiraglutideTsis tas li ntawd eases rov qab gastric purging, implying hais tias cov zaub mov tsiv tag nrho cov ntau leisurely ntawm lub plab mus rau hauv lub me digestive system. Lub sijhawm ntev ntawm cov zaub mov hauv plab no ua rau muaj kev xav ntau ntxiv thiab txo cov khoom noj tag nrho.

Tsis tas li ntawd, nws tau pom tias raglutide txhim kho lub zog metabolism. Nws tuaj yeem nce kev siv lub zog, ua rau muaj cov calorie ntau ntau tau noj nyob rau ib hnub. Qhov kev cuam tshuam no, koom nrog kev txo qis hauv caloric nkag, ua rau cov calories tsis txaus, nce qhov hnyav.

Cov kev tshawb fawb soj ntsuam tau pom qhov txaus ntawm Liraglutide rau kev txo qhov hnyav. Hauv SCALE Stoutness thiab Prediabetes ua ntej, cov tswv cuab uas tau txais Liraglutide 3.0 mg ib hnub rau ib hnub, nrog rau txoj kev sib kho hauv lub neej, ua tiav qhov hnyav li qub ntawm 8.4% ntau dua 56 lub lis piam, sib piv nrog 2.8% hauv qhov cuav kev kho mob pawg. Cov txiaj ntsig no qhia txog lub peev xwm ntawm Liraglutide ua ib qho cuab yeej tseem ceeb hauv kev tswj kev rog.

Nws yog ib qho tseem ceeb uas yuav tsum nco ntsoov tias Liraglutide tsis yog ib qho kev kho mob tag nrho rau kev poob phaus. Kev noj zaub mov tsawg hauv calories thiab ua kom lub cev muaj zog yuav tsum sib koom tes. Cov tib neeg uas muaj BMI ntawm 30 lossis siab dua lossis BMI ntawm 27 lossis siab dua thiab tsis pub tsawg dua ib qho kev hnyav hnyav, xws li kub siab lossis dyslipidemia, tsis tu ncua tau laglutide ib yam nkaus.

Liraglutide tau pom cov lus cog tseg rau kev poob phaus, tab sis tsis yog txhua tus yuav tsum siv nws. Liraglutide yuav tsum tsis txhob siv los ntawm ib tus neeg uas muaj medullary thyroid carcinoma lossis ntau yam endocrine neoplasia syndrome hom 2 hauv lawv tsev neeg lossis yav dhau los. Tsis tas li ntawd, cov neeg uas muaj keeb kwm yav dhau los ntawm tus kab mob pancreatitis yuav tsum tau xyaum kev ceeb toom thiab tshuaj xyuas qhov txaus ntshai thiab qhov zoo nrog lawv tus kws kho mob ua ntej pib kho Liraglutide.

Cov kev phiv ntawm Liraglutide yog dab tsi?

Feem ntau ntawm cov teebmeem thib ob yog maj mam thiab luv luv, thiab lawv ploj mus thaum lub cev hloov nrog cov tshuaj. Txawm li cas los xij, ob peb tus neeg tuaj yeem ntsib ntau dua lossis mob siab rau cov teebmeem thib ob uas xav tau kev kho mob.

Cov tib neeg uas muaj kev mob tshwm sim hnyav los yog tsis tu ncua yuav tsum sab laj nrog lawv tus kws kho mob tam sim ntawd. Qee qhov xwm txheej, kho qhov ntau npaum lossis txiav cov tshuaj yuav tsum tau ua.

Raglutide yuav tsum tau pib ntawm qhov qis thiab nthuav dav raws li kev ua siab ntev tom qab qee lub sijhawm kom txo qis kev twv txiaj ntawm kev cuam tshuam tsis zoo. Yog tias noj nrog zaub mov, raglutide kuj tseem tuaj yeem txo cov kev mob plab hnyuv xws li xeev siab thiab raws plab.

Nws yog ib qho tseem ceeb rau cov neeg xav txogLiraglutidekev kho mob los tham txog lawv cov keeb kwm kho mob, cov tshuaj uas twb muaj lawm, thiab xav tias yuav siv sij hawm nrog lawv tus kws kho mob. Qhov no ua rau muaj kev saib xyuas tsim nyog thiab kev tswj xyuas txhua yam kev mob tshwm sim, nrog rau kev soj ntsuam tus kheej ntawm cov txiaj ntsig thiab qhov tsis zoo ntawm kev siv Liraglutide.

Liraglutide puas tuaj yeem siv rau kev kho mob ntshav qab zib hom 2?

Raglutide tau tshwm sim hauv kev kuaj mob kom txo qis kev twv txiaj ntawm cov ntshav qab zib tsis meej pem thiab txhim kho glycemic tswj. Liraglutide tag nrho txo ​​qis qhov kev twv txiaj ntawm cov xwm txheej loj ntawm cov hlab plawv, piv txwv li, mob hlab ntsha tawg thiab mob hlab ntsha tawg, hauv cov tib neeg uas muaj ntshav qab zib hom 2 thiab kev ua si plawv siab hauv Pioneer ua ntej.

Liraglutide feem ntau yog txhaj tshuaj subcutaneously ib zaug ib hnub los kho cov ntshav qab zib hom 2, pib ntawm koob tshuaj tsawg ua ntej maj mam nce mus rau cov tshuaj noj.

Liraglutide tuaj yeem siv ib leeg lossis cuam tshuam nrog insulin, sulfonylureas, metformin, lossis lwm yam tshuaj ntshav qab zib. Qhov kev txiav txim siab ntawm kev kho mob niaj hnub tso siab rau ntau qhov sib txawv, suav nrog tus neeg tswj glycemic, comorbidities, thiab ib tus neeg inclinations.

Thaum Liraglutide muaj ntau yam txiaj ntsig hauv kev tswj hwm ntshav qab zib hom 2, nws tsis haum rau txhua tus. Cov tib neeg uas muaj keeb kwm ntawm tus mob pancreatitis, medullary thyroid carcinoma, lossis ntau yam endocrine neoplasia syndrome hom 2 yuav tsum tsis txhob siv Liraglutide. Tsis tas li ntawd, cov neeg uas muaj kab mob plab hnyuv loj los yog lub raum tsis ua haujlwm yuav tsum tau kho cov koob tshuaj lossis lwm yam kev kho mob.

ThaumLiraglutidekev kho mob, nws yog ib qho tseem ceeb rau kev saib xyuas lub raum muaj peev xwm, qib ntshav qabzib, thiab lwm yam tseem ceeb ciam teb tas li. Ib yam li ntawd, cov tib neeg yuav tsum tau qhia tias yuav ua li cas pom thiab kho hypoglycemia, nrog rau qhov tseeb tias nws yog qhov tseem ceeb heev uas yuav tsum tau noj zaub mov zoo thiab ua haujlwm tsis tu ncua.

Hauv cov ntsiab lus, Liraglutide yog ib qho kev xaiv zoo rau kev kho mob ntshav qab zib hom 2, muab cov khoom sib txawv ntawm kev ua ub no los txhim kho glycemic tswj thiab txo qis kev twv txiaj ntawm cov ntshav qab zib tsis meej pem. Rau kev tswj hwm zoo, kev txhim kho ib txwm nrog tus neeg muab kev kho mob yog qhov tseem ceeb, thiab nws txoj kev siv yuav tsum tau ua raws li tus neeg mob qhov zoo thiab keeb kwm kev kho mob.

Xaus

Liraglutide thiab Semaglutide yog ob qho tib si GLP-1 receptor agonists nrog cov txheej txheem zoo sib xws, tab sis lawv muaj qhov sib txawv ntawm lawv cov khoom siv tshuaj thiab kev siv tshuaj kho mob. Liraglutide, muaj nyob rau hauv cov npe lag luam Saxenda rau kev poob phaus thiab Victoza rau kev kho mob ntshav qab zib hom 2, tau pom tias txhawb kev poob phaus los ntawm kev txo qis qab los noj mov, ua rau lub plab zom mov qeeb, thiab nce kev siv zog. Nws kuj tseem tswj hwm cov ntshav qab zib hom 2 tau zoo los ntawm kev txhim kho cov piam thaj-dependent insulin secretion, suppressing glucagon secretion, thiab ua rau lub plab zom mov qeeb.

Txawm li cas los xij, zoo li txhua yam tshuaj, Liraglutide tuaj yeem ua rau muaj kev phiv, xws li cov tsos mob ntawm plab hnyuv me mus rau qhov tsis tshua muaj tab sis mob hnyav xws li mob pancreatitis thiab thyroid qog. Cov tib neeg xav txog kev kho liraglutide yuav tsum muaj kev sib tham zoo nrog lawv tus kws kho mob los soj ntsuam cov txiaj ntsig thiab kev pheej hmoo raws li lawv cov keeb kwm kho mob thiab kev noj qab haus huv tam sim no.

Nyob rau hauv sib piv, Semaglutide, muaj nyob rau hauv lub npe hom Ozempic thiab Rybelsus, muaj ib nrab-lub neej ntev thiab yuav tsum tau tsawg dua kev tswj hwm piv rau Liraglutide. Nws kuj tau ua kom pom kev poob phaus zoo dua thiab tswj glycemic hauv kev sim tshuaj xyuas lub taub hau rau Liraglutide.

Kev xaiv ntawm Liraglutide thiab Semaglutide nyob ntawm ntau yam, suav nrog tus neeg mob tus yam ntxwv, lub hom phiaj kev kho mob, thiab kev ua siab ntev. Cov kws kho mob yuav tsum xav txog cov xwm txheej no thaum pom zoo GLP -1 receptor agonist uas tsim nyog tshaj rau lawv cov neeg mob.

Raws li thaj chaw ntawm kev rog rog thiab kev tswj ntshav qab zib hom 2 txuas ntxiv mus, GLP-1 receptor agonists nyiamLiraglutidethiab Semaglutide muab kev cia siab rau cov tib neeg nrhiav kev txhim kho lawv cov txiaj ntsig kev noj qab haus huv. Kev tshawb fawb tsis tu ncua yuav qhia ntxiv txog cov txiaj ntsig ntev thiab kev pheej hmoo ntawm cov tshuaj no, coj lawv txoj kev siv zoo hauv kev kho mob.

Cov ntaub ntawv

1. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & Wilding, JP (2015) . Ib qho randomized, tswj kev sim ntawm 3.0 mg ntawm liraglutide hauv kev tswj qhov hnyav. New England Journal of Medicine, 373(1), 11-22.

2. Marso, SP, Daniels, GH, Brown-Frandsen, K., Kristensen, P., Mann, JF, Nauck, MA, ... & Steinberg, WM (2016). Liraglutide thiab cov txiaj ntsig ntawm cov hlab plawv hauv ntshav qab zib hom 2. New England Journal of Medicine, 375(4), 311-322.

3. Mehta, A., Marso, SP, & Neeland, IJ (2017). Liraglutide rau kev tswj qhov hnyav: kev tshuaj xyuas tseem ceeb ntawm cov pov thawj. Obesity Science & Practice, 3(1), 3-14.

4. Pratley, R., Amod, A., Hoff, ST, Kadowaki, T., Lingvay, I., Nauck, M., ... & PIONEER 4 Cov Neeg Tshawb Fawb. (2019). Qhov ncauj semaglutide piv rau subcutaneous liraglutide thiab placebo hauv hom 2 mob ntshav qab zib (PIONEER 4): ib qho randomised, ob-dig muag, theem 3a sim. Lub Lancet, 394(10192), 39-50.

5. Drucker, DJ, Buse, JB, Taylor, K., Kendall, DM, Trautmann, M., Zhuang, D., ... & DURATION-1 Pawg Kawm. (2008). Exenatide ib zaug ib lub lim tiam piv rau ob zaug ib hnub rau kev kho mob ntshav qab zib hom 2: ib qho kev sib tw, qhib-label, tsis yog kev kawm tsis zoo. Lub Lancet, 372(9645), 1240-1250.

6. Knudsen, LB, & Lau, J. (2019). Kev tshawb pom thiab kev loj hlob ntawm liraglutide thiab semaglutide. Frontiers hauv Endocrinology, 10, 155.

7. Filippatos, TD, Panagiotopoulou, TV, & Elisaf, MS (2014). Cov teebmeem tsis zoo ntawm GLP-1 receptor agonists. Kev Tshawb Fawb Txog Kev Tshawb Fawb Kev Mob Ntshav Qab Zib: RDS, 11(3-4), 202-230.

8. Bjerre Knudsen, L., Madsen, LW, Andersen, S., Almholt, K., de Boer, AS, Drucker, DJ, ... & Tuulari, JJ (2010). Glucagon-zoo li peptide-1 receptor agonists ua rau nas cov thyroid C-hlwb ua rau calcitonin tso tawm thiab C-cell proliferation. Endocrinology, 151(4), 1473-1486.

9. Nauck, MA, Quast, DR, Wefers, J., & Meier, JJ (2021). GLP-1 receptor agonists hauv kev kho mob ntshav qab zib hom 2-xeev-ntawm-the-art. Molecular Metabolism, 46, 101102.

10. Wilding, JP, Batterham, RL, Calanna, S., Davies, M., Van Gaal, LF, Lingvay, I., ... & STEP 1 Pawg Kawm. (2021). Ib zaug ib lub lim tiam semaglutide rau cov neeg laus uas rog dhau lossis rog. New England Journal of Medicine, 384(11), 989-1002.